Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives

References

• Peterson KM, Gellings PS. Multiple intraintestinal signals coordinate the regulation of Vibrio cholerae virulence determinants. Pathog Dis 2018;76.
   PubMed Web of Science ®Google Scholar
• Muanprasat C, Chatsudthipong V. Cholera: pathophysiology and emerging therapeutic targets. Future Med Chem 2013;5:781–98.
   PubMed Web of Science ®Google Scholar
• Thomson JJ, Withey JH. Bicarbonate increases binding affinity of Vibrio cholerae ToxT to virulence gene promoters. J Bacteriol 2014;196:3872–80.
   PubMed Web of Science ®Google Scholar
• Cobaxin M, Martinez H, Ayala G, et al. Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditions. Microb Pathog 2014;66:5–13.
   PubMed Web of Science ®Google Scholar
• Lomelino CL, Andring JT, McKenna R. Crystallography and its impact on carbonic anhydrase research. Int J Med Chem 2018;2018:9419521.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 2015;19:1689–704.
   PubMed Web of Science ®Google Scholar
• Modak JK, Liu YC, Machuca MA, et al. Structural basis for the inhibition of Helicobacter pylori alpha-carbonic anhydrase by sulfonamides. PLoS One 2015;10:e0127149.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23:693–704.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Inhibition of bacterial carbonic anhydrases as a novel approach to escape drug resistance. Curr Top Med Chem 2017;17:1237–48.
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12.
   PubMed Web of Science ®Google Scholar
• De Luca L, Mancuso F, Ferro S, et al. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases. Eur J Med Chem 2018;143:276–82.
   PubMed Web of Science ®Google Scholar
• Bruno E, Buemi MR, Di Fiore A, et al. Probing molecular interactions between Human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides. J Med Chem 2017;60:4316–26.
   PubMed Web of Science ®Google Scholar
• Bruno E, Buemi MR, De Luca L, et al. In vivo evaluation of selective carbonic anhydrase inhibitors as potential anticonvulsant agents. ChemMedChem 2016;11:1812–8.
   PubMed Web of Science ®Google Scholar
• Buemi MR, De Luca L, Ferro S, et al. Carbonic anhydrase inhibitors: design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms. Eur J Med Chem 2015;102:223–32.
   PubMed Web of Science ®Google Scholar
• De Luca L, Ferro S, Damiano FM, et al. Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors. Eur J Med Chem 2014;71:105–11.
   PubMed Web of Science ®Google Scholar
• Gitto R, Damiano FM, Mader P, et al. Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors. J Med Chem 2012;55:3891–9.
   PubMed Web of Science ®Google Scholar
• Gitto R, Damiano FM, De Luca L, et al. Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors. Bioorg Med Chem 2011;19:7003–7.
   PubMed Web of Science ®Google Scholar
• Mader P, Brynda J, Gitto R, et al. Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. J Med Chem 2011;54:2522–6.
   PubMed Web of Science ®Google Scholar
• Gitto R, Agnello S, Ferro S, et al. Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors. ChemMedChem 2010;5:823.
   PubMed Web of Science ®Google Scholar
• Gitto R, Agnello S, Ferro S, et al. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme-ligand X-ray studies. J Med Chem 2010;53:2401–8.
   PubMed Web of Science ®Google Scholar
• Gitto R, Ferro S, Agnello S, et al. Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. Bioorg Med Chem 2009;17:3659–64.
   PubMed Web of Science ®Google Scholar
• Buemi MR, Di Fiore A, De Luca L, et al. Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety. Eur J Med Chem 2019;163:443–52.
   PubMed Web of Science ®Google Scholar
• De Luca V, Del Prete S, Supuran CT, et al. Protonography, a new technique for the analysis of carbonic anhydrase activity. J Enzyme Inhib Med Chem 2015;30:277–82.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. Anion inhibition profiles of alpha-, beta- and gamma-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem 2016;24:3413–7.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. Anion inhibition profiles of the complete domain of the eta-carbonic anhydrase from Plasmodium falciparum. Bioorg Med Chem 2016;24:4410–4.
   PubMed Web of Science ®Google Scholar
• De Luca V, Vullo D, Del Prete S, et al. Cloning, characterization and anion inhibition studies of a gamma-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea. Bioorg Med Chem 2016;24:835–40.
   PubMed Web of Science ®Google Scholar
• Ferraroni M, Del Prete S, Vullo D, et al. Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Acta Crystallogr D Biol Crystallogr 2015;71:2449–56.
   PubMedGoogle Scholar
• Discovery Studio 2.5.5 Accelrys. Biovia, San Diego, CA; 2009. [cited 2019 Jun 13]. Available from: http://www.accelrys.com.
   Google Scholar
• Huang S, Hainzl T, Grundstrom C, et al. Structural studies of beta-carbonic anhydrase from the green alga Coccomyxa: inhibitor complexes with anions and acetazolamide. PLoS One 2011;6:e28458.
   PubMed Web of Science ®Google Scholar
• Pedretti A, Villa L, Vistoli G. VEGA - An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J Comput-Aided Mol Des 2004;18:167–73.
   PubMed Web of Science ®Google Scholar
• Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 2005;45:160–9.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727–48.
   PubMed Web of Science ®Google Scholar
• Phillips JC, Braun R, Wang W, et al. Scalable molecular dynamics with NAMD. J Comput Chem 2005;26:1781–802.
   PubMed Web of Science ®Google Scholar
• Cronk JD, O'Neill JW, Cronk MR, et al. Cloning, crystallization and preliminary characterization of a beta-carbonic anhydrase from Escherichia coli. Acta Crystallogr D Biol Crystallogr 2000;56:1176.
   PubMed Web of Science ®Google Scholar
• Rowlett RS, Tu C, Lee J, et al. Allosteric site variants of Haemophilus influenzae beta-carbonic anhydrase. Biochemistry 2009;48:6146–56.
   PubMed Web of Science ®Google Scholar
• Covarrubias AS, Bergfors T, Jones TA, et al. Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis. J Biol Chem 2006;281:4993–9.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Vullo D, et al. Inhibition studies of the beta-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. Bioorg Med Chem 2011;19:5023–30.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 2011;51:2778–86.
   PubMed Web of Science ®Google Scholar